Acyclovir Substitution For VZIG To Prevent Severe Chickenpox Is Topic Of Advisory Cmte.
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA asks committee whether prevention of severe varicella zoster infection could be achieved with acyclovir or immune globulin treatment. Meanwhile, the agency is seeking to expedite approval of varicella zoster immune globulin products.